China's CSPC outlicenses unspecified generic oncology drug to Watson in $106M deal

Allergan headquarters

Shijiazhuang-based CSPC Pharmaceutical Group signed a potential $106 million deal to outlicense a complex a generic oncology drug to Allergan ($AGN) unit Watson Laboratories of the U.S.

Under the terms, according to a statement to the Hong Kong Stock Exchange, Watson will pay the potential milestones and royalties for the unspecified product under development by the Chinese drugmaker's CSPC Zhongqi unit "utilizing its proprietary technology."

CSPC--one of China's top drug exporters that now includes active pharmaceutical ingredients after the merger of four companies based in Hebei province--said the drug is now in preclinical work and the company is also slated to insure international Good Manufacturing Practice norms.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

The drug will be manufactured by CSPC, with Watson gaining rights outside of China as well as holding responsibility for approvals in assigned regions. The company has moved into in-house discovery efforts across oncology, cardio and traditional Chinese medicines.

In April, CSPC's Hebei Yongfeng Yaoye unit was one of three firms hauled up by China FDA for manufacturing lapses, leading to product recalls over suspected faulty origin, labelling, data and quality assessments.

- here's the release

Suggested Articles

FDA officials say Novartis took too long to launch a formal probe into allegations of Zolgensma data manipulation.

Should Johnson & Johnson owe billions to fix Oklahoma's opioid crisis? After weeks of trial testimony, a judge will have his say Monday afternoon.

After Endo and Allergan agreed to settle with two Ohio counties on opioid charges this week, the state’s AG has a message: You’re not off the hook.